Paper Details

  1. Home
  2. Paper Details

Collagenase clostridium histolyticum injection for the treatment of Dupuytren's contracture.

Author: KaplanF T D

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Collagenase clostridium histolyticum is a new treatment for Dupuytren's contracture, a disorder that causes the fingers to bend and become stiff. The medication was found to be effective in reducing contracture in most patients, and the majority of side effects were mild and short-lived.
Paper Details　
Original Abstract of the Article :
Collagenase clostridium histolyticum is a novel treatment for Dupuytren's contracture, approved by the U.S. Food and Drug Administration in February 2010. Prior to its availability, surgery was the only treatment for contracture related to this disorder. Dupuytren's disease is a benign, progressive ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1358/dot.2011.47.9.1656502

データ提供：米国国立医学図書館（NLM）

A New Treatment for Dupuytren's Contracture

Dupuytren's contracture, a disorder that affects the palms of the hands, can be as frustrating as a sandstorm in the desert. This study explores a new treatment, collagenase clostridium histolyticum, which is like a gentle wind clearing the path for a more comfortable life.

Collagenase Clostridium Histolyticum: A Promising Option

The research delves into the effectiveness of collagenase clostridium histolyticum in treating Dupuytren's contracture. It is like a skilled artisan carefully sculpting a solution to a problem, achieving a statistically significant reduction in contracture compared to placebo. The study highlights the safety and tolerability of the treatment, making it a viable alternative to surgery.

Hope for Patients with Dupuytren's Contracture

This study offers hope for patients suffering from Dupuytren's contracture. The researchers have discovered a new treatment that is like a cool spring in the desert, providing relief and improving quality of life.

Dr.Camel's Conclusion

This study provides a promising new treatment option for patients with Dupuytren's contracture. The research is a testament to the power of innovation in addressing health challenges, like a camel caravan traversing the desert to find a new oasis.
Date :
  1. Date Completed 2012-04-10
  2. Date Revised 2022-03-09
Further Info :

Pubmed ID

21971540

DOI: Digital Object Identifier

10.1358/dot.2011.47.9.1656502

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.